ArticleJournal of neuroendocrinology2025
Pituitary gonadotropin-releasing hormone II as a possible mediator of positive estrogen feedback.
Article in Journal of neuroendocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Evaluating the contraceptive potential of active immunization against gonadotropin-releasing hormone.Reproduction (Cambridge, England) · 2026Article
- Pituitary gonadotropin-releasing hormone II as a possible mediator of positive estrogen feedback.Journal of neuroendocrinology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
It has previously been shown that rhesus macaques express two forms of gonadotropin-releasing hormone (GNRH1 and GNRH2) in the hypothalamus and that both forms can stimulate the release of luteinizing hormone (LH) in vivo. However, while much has been published about the role of GNRH1 in reproduction, very little is known about the hypophysiotropic function of GNRH2. To shed light on this issue, we studied the expression pattern of these two genes in different parts of the monkey hypothalamus and pituitary gland under controlled conditions of circulating estrogen levels, using qPCR, liquid chromatography with tandem mass spectrometry and RNAscope. GNRH1/GNRH1 expression was found throughout the hypothalamus and was largely unaffected by circulating estradiol levels. In contrast, GNRH2/GNRH2 expression was found to be enhanced by long-term treatment with estradiol and during the late follicular phase of the menstrual cycle, especially in the arcuate nucleus and pituitary gland. Together these findings suggest that pituitary GNRH2/GNRH2 (but not GNRH1/GNRH1) is induced by positive feedback-like levels of estradiol. This novel finding raises the possibility that GNRH2 plays a major role in triggering the preovulatory LH surge in primates, not only at the level of the hypothalamus but also the pituitary gland.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.